APPLICATION
NDA214793
TYPE
NDA
ORIGINAL APPROVAL
2021-05-26
LATEST ACTION
2021-05-26
ROUTE
INTRAVENOUS
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
PYLARIFY · ReferencePrescription
PIFLUFOLASTAT F-18 50ML (1-80mCi/ML) · SOLUTION · INTRAVENOUS
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.